HLB Inc Share Price Korea S.E.
Equities
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
||
- | - |
|
04/07 | HLB Stock Soars Amid FDA Re-Approval Efforts for Liver Cancer Drug | MT |
14/05 | HLB Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Sales 2022 | 18TCr 13Cr 0 1.09TCr | Sales 2023 | 4.29TCr 3.11Cr 0 260.17Cr | Capitalization | 6,54200Cr 474.95Cr 0 40TCr |
---|---|---|---|---|---|
Net income 2022 | -7.82TCr -5.67Cr - -473.99Cr | Net income 2023 | -19TCr -14Cr - -1.15TCr | EV / Sales 2022 | 17.5 x |
Net cash position 2022 | 17TCr 12Cr 0 1.02TCr | Net cash position 2023 | 4.93TCr 3.58Cr 0 299.01Cr | EV / Sales 2023 | 151 x |
P/E ratio 2022 |
-40.6
x | P/E ratio 2023 |
-32.5
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 90.2% |
Managers | Title | Age | Since |
---|---|---|---|
Yang-Gon Jin
CEO | Chief Executive Officer | 58 | - |
Hyuk Joo Jee
PRN | Corporate Officer/Principal | - | - |
Yong-Woong Kim
AUD | Comptroller/Controller/Auditor | 66 | 29/12/29 |
Members of the board | Title | Age | Since |
---|---|---|---|
Yang-Gon Jin
CEO | Chief Executive Officer | 58 | - |
Jin-Gook Park
BRD | Director/Board Member | 76 | 07/17/07 |
Sung-Je Kim
BRD | Director/Board Member | 58 | - |
1st Jan change | Capi. | |
---|---|---|
-5.50% | 18TCr | |
-5.79% | 9.95TCr | |
-6.59% | 6.58TCr | |
-8.38% | 4.52TCr | |
+8.42% | 4.39TCr | |
+10.10% | 4.22TCr | |
+10.97% | 2.87TCr | |
+18.89% | 2.54TCr | |
-8.39% | 2.35TCr |